LGALS9 and myelodysplastic syndrome: Studies have reported that a higher percentage of TIM-3 reflects a higher risk for myelodysplastic syndrome (MDS) transformation to leukemia as increased levels of TIM-3 and its ligand, Gal-9 is reported on bone marrow cells and MDSCs from MDS patients [90,91].